Molecules / Anagrelide

Anagrelide API manufacturers

CAS 68475-42-3 ATC L01XX35 Updated 9 July 2026
7
manufacturers with an active filing 7 of them hold a US DMF or a CEP
15
shortage records on file across 3 countries
201
finished-dose makers across 29 regulators
Showing 7 of 7 manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked API manufacturers

01

Olpha

Latvia
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for anagrelide, filing since 2003. Its 2024 FDA inspection closed as NAI, and its GMP is recognised in 9 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2024 · NAI
GMP recognised in
9 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
02

Torrent Pharmaceuticals

India
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for anagrelide, filing since 2015. Its 2026 FDA inspection closed as NAI, and its GMP is recognised in 20 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2026 · NAI
GMP recognised in
20 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
03

Micro Labs

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for anagrelide, filing since 2022. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 20 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
20 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
04

Piramal Pharma

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for anagrelide, filing since 2023. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 10 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
10 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
05

Cipla

India
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for anagrelide, filing since 2002. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 34 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
34 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
06

Zydus Lifesciences

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for anagrelide, filing since 2003. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 25 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
25 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
07

Ash Stevens

United States
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for anagrelide, filing since 2002.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile

4 more manufacturers hold filings for anagrelide

The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.

Piramal PharmaCiplaZydus LifesciencesAsh Stevens
Open the full list with a free account

Contract manufacturers (1)

ChemCon Germany

Contract manufacturers make to order rather than holding their own filing for this molecule.

Finished-dose makers (23)

Patheon Manufacturing Services United States Pharmascience Canada Zentiva, k.s Czech Republic Glenmark Pharmaceuticals s.r.o Czech Republic Sandoz Switzerland Viatris United States ANI Pharmaceuticals United States Chartwell RX United States Takeda Germany Orion Finland STADA Arzneimittel Germany AOP Orphan Pharmaceuticals Austria Aristo Pharma Germany Ems S/A Brazil Marcyrl Pharmaceutical Industries Egypt Takeda Pharma Ltda Brazil Teva Israel Laboratorios Legrand S A Colombia Novem Pharma Rising United States

How this list is built

The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.

Active US DMFs
FDA, List of Drug Master Files
Valid CEPs
EDQM certificate database
Inspection outcomes
FDA inspection classifications
GMP certificates
EudraGMDP and national regulators

Map anagrelide for your markets

Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.

Start for free
No sales call.

Also on this molecule

Shortages 15 Recalls 3 Finished dose 23 Contract mfrs 1

By country

India 8